Singh RB - Search Results

1

Suppression of Neovascularization by Topical and Subconjunctival Bevacizumab After High-Risk Corneal Transplantation.

Dohlman TH, Singh RB, Amparo F, Carreno-Galeano T, Dastjerdi M, Coco G, Di Zazzo A, Shikari H, Saboo U, Sippel K, Ciralsky J, Yoo SH, Sticca M, Wakamatsu TH, Murthy S, Hamrah P, Jurkunas U, Ciolino JB, Saeed H, Gomes JAP, Perez VL, Yin J, Dana R. Dohlman TH, et al. Among authors: singh rb. Ophthalmol Sci. 2024 Feb 13;4(4):100492. doi: 10.1016/j.xops.2024.100492. eCollection 2024 Jul-Aug. Ophthalmol Sci. 2024. PMID: 38682029 Free PMC article.

2

Artificial Intelligence (AI) for Early Diagnosis of Retinal Diseases.

Parmar UPS, Surico PL, Singh RB, Romano F, Salati C, Spadea L, Musa M, Gagliano C, Mori T, Zeppieri M. Parmar UPS, et al. Among authors: singh rb. Medicina (Kaunas). 2024 Mar 23;60(4):527. doi: 10.3390/medicina60040527. Medicina (Kaunas). 2024. PMID: 38674173 Free PMC article. Review.

3

Effects of Diabetes Mellitus on Corneal Immune Cell Activation and the Development of Keratopathy.

Surico PL, Narimatsu A, Forouzanfar K, Singh RB, Shoushtari S, Dana R, Blanco T. Surico PL, et al. Among authors: singh rb. Cells. 2024 Mar 18;13(6):532. doi: 10.3390/cells13060532. Cells. 2024. PMID: 38534376 Free PMC article.

4

Local administration of myeloid-derived suppressor cells prevents progression of immune-mediated dry eye disease.

Surico PL, Lee S, Singh RB, Naderi A, Bhullar S, Blanco T, Chen Y, Dana R. Surico PL, et al. Among authors: singh rb. Exp Eye Res. 2024 May;242:109871. doi: 10.1016/j.exer.2024.109871. Epub 2024 Mar 26. Exp Eye Res. 2024. PMID: 38527580

5

Demographic Characteristics, Clinical Presentations, and Risk Factors Impacting Visual Outcomes in Peripheral Ulcerative Keratitis.

Singh RB, Atta S, Srikumaran D, Jhanji V. Singh RB, et al. Cornea. 2024 Mar 14. doi: 10.1097/ICO.0000000000003541. Online ahead of print. Cornea. 2024. PMID: 38483828

6

Topical application of calcitonin gene-related peptide as a regenerative, antifibrotic, and immunomodulatory therapy for corneal injury.

Zidan AA, Zhu S, Elbasiony E, Najafi S, Lin Z, Singh RB, Naderi A, Yin J. Zidan AA, et al. Among authors: singh rb. Commun Biol. 2024 Mar 4;7(1):264. doi: 10.1038/s42003-024-05934-y. Commun Biol. 2024. PMID: 38438549 Free PMC article.

7

Molecular Targets of Valeric Acid: A Bioactive Natural Product for Endocrine, Metabolic, and Immunological Disorders.

Kumari B, Kumari U, Singh DK, Husain GM, Patel DK, Shakya A, Singh RB, Modi GP, Singh GK. Kumari B, et al. Among authors: singh rb. Endocr Metab Immune Disord Drug Targets. 2024 Feb 16. doi: 10.2174/0118715303262653231120043819. Online ahead of print. Endocr Metab Immune Disord Drug Targets. 2024. PMID: 38375842

8

Design, synthesis, molecular docking and pharmacological evaluation of some thiadiazole based nipecotic acid derivatives as a potential anticonvulsant and antidepressant agents.

Singh GK, Kumari B, Das N, Zaman K, Prasad P, Singh RB. Singh GK, et al. Among authors: singh rb. 3 Biotech. 2024 Mar;14(3):71. doi: 10.1007/s13205-023-03897-1. Epub 2024 Feb 13. 3 Biotech. 2024. PMID: 38362592

9

Response to Comment on: Prevalence and Economic Burden of Keratoconus in the United States.

Singh RB, Parmar UPS, Jhanji V. Singh RB, et al. Am J Ophthalmol. 2024 Apr;260:213. doi: 10.1016/j.ajo.2024.01.028. Epub 2024 Feb 1. Am J Ophthalmol. 2024. PMID: 38309454 No abstract available.

10

Imaging 3.0: A scoping review.

Alami Idrissi Y, Virador GM, Singh RB, Rao D, Stone JA, Sandhu SJS. Alami Idrissi Y, et al. Among authors: singh rb. Curr Probl Diagn Radiol. 2024 May-Jun;53(3):399-404. doi: 10.1067/j.cpradiol.2024.01.012. Epub 2024 Jan 17. Curr Probl Diagn Radiol. 2024. PMID: 38242771 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

540 results

Search Page